Magnetic susceptibility measurements have shown that the compounds Mn(1-x)Fe(x)Ge are magnetically ordered through the whole range of concentrations x = [0.0,1.0]. Small-angle neutron scattering reveals the helical nature of the spin structure with a wave vector, which changes from its maximum (|k| = 2.3 nm(-1)) for pure MnGe, through its minimum (|k| → 0) at x(c) ≈ 0.75, to the value of |k| = 0.09 nm(-1) for pure FeGe. The macroscopic magnetic measurements confirm the ferromagnetic nature of the compound with x = x(c). The observed transformation of the helix structure to the ferromagnet at x = x(c) is explained by different signs of chirality for the compounds with x > x(c) and x
International audienceWe have studied the MnGe chiral magnet below T N = 170 K, by magnetic measurements, Mössbauer spectroscopy, and by neutron diffraction at ambient and under nonhydrostatic pressure. At ambient pressure, we observe the coexistence of two magnetic phases belonging to the same crystal phase in a large temperature range (down to 100 K) below T N : ferromagnetically correlated rapidly fluctuating spins coexist with frozen spins involved in the helical order. Applying a uniaxial pressure component induces a strong magnetic texture, where most of the helical axes reorient along the stress axis. The magnetic texture persists in the fluctuating chiral state up to T N. Our results suggest that the zero field ground state at ambient pressure is a multidomain state consisting of helical domains with random orientations rather than a three-dimensional skyrmion lattice. They show the presence of an unusually broad transition to paramagnetism with a dynamical phase separation triggered by temperature
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.